Skip to content

Total raised

$31.2M

+$31.2M this year

2 filings since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $11.2M
ROUNDS
2
INVESTORS
2
FOUNDED
N/A
HQ
Hudson, MA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
N/A

AI overview

Updated

Lifeward Ltd. is a Nasdaq-listed medical device company (LFWD) that develops and sells wearable robotic exoskeletons and other rehabilitation and recovery technology. It was founded as ReWalk Robotics in 2001 and completed its rename to Lifeward in September 2024 after acquisitions broadened the portfolio beyond exoskeletons. Its products serve people with spinal cord injury, stroke, and other neurological or orthopedic conditions, sold to rehabilitation clinics and to individuals. It is headquartered at 2 Cabot Road in Hudson, Massachusetts, with additional offices in Berlin, Germany and Yokneam Ilit, Israel.

What sets it apart

One portfolio spanning the rehabilitation continuum from clinic to home, anchored by the ReWalk personal exoskeleton, the only product line of its kind marketed for personal use by people with spinal cord injury in the US.

Funding history

2 rounds
Equity+3Jul 6, 2026
Form D
+$11.2M$31.2M total
Equity+3Mar 25, 2026
Form D
+$20.0M$20.0M total

Products

1 tracked

ReWalk Personal Exoskeleton

Wearable robotic medical device

A wearable robotic exoskeleton that provides powered hip and knee motion, enabling individuals with spinal cord injury to stand upright, walk, turn, and climb and descend stairs. The seventh generation, ReWalk 7, became available nationwide in the US in April 2025.

  • Powered hip and knee motion
  • Stair ascent and descent
  • Designed for personal, at-home use rather than clinic-only
  • ReWalk 7 current generation, launched in the US in April 2025